• Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival 

      Stensvold, Einar; Myklebust, Tor Åge; Cappelen, Johan; Due-Tønnessen, Bernt Johan; Due-Tønnessen, Paulina; Kepka, Aleksandra; Johannessen, Tom Børge; Krossnes, Bård Kronen; Lundar, Tryggve; Maric, Snezana; Miletic, Hrvoje; Moholdt, Viggo; Myrmel, Kristin Smistad; Nordberg, Terje; Rydland, Jana; Stokland, Tore; Solem, Kristin; Solheim, Ole; Torsvik, Ingrid Kristin; Wikran, Gry Charlotte; Zeller, Bernward; Wesenberg, Finn; Bechensteen, Anne Grete; Brandal, Petter (Peer reviewed; Journal article, 2019)
      Background: A previous study based on Norwegian Cancer Registry data suggested regional differences in overall survival (OS) after treatment for medulloblastoma (MB) and supratentorial primitive neuroectodermal tumor ...
    • DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia 

      Borssén, Magnus; Haider, Zahra; Landfors, Mattias; Norén-Nyström, Ulrika; Schmiegelow, Kjeld; Åsberg, Ann Elisabeth; Kanerva, Jukka; Madsen, Hans O.; Marquart, Hanne; Heyman, Mats; Hultdin, Magnus; Roos, Göran; Forestier, Erik; Degerman, Sofie (Peer reviewed; Journal article, 2016)
      Background. Despite increased knowledge about genetic aberrations in pediatric T-cell acute lymphoblastic leukemia (T-ALL), no clinically feasible treatment-stratifying marker exists at diagnosis. Instead patients are ...